Esperite N.V.: announces termination of audit engagement in relation to 2018 annual report
July 04, 2019 02:58 ET
|
Esperite N.V.
ESPERITE (ESP) announces termination of audit engagement in relation to 2018 annual report Amsterdam, The Netherlands – 3 July 2019Esperite N.V. (Euronext: ESP, “Esperite”) announces that its...
ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE.
July 02, 2019 02:47 ET
|
Esperite N.V.
ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE. ...
ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business.
June 30, 2019 15:01 ET
|
Esperite N.V.
ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business. CEO, Frédéric Amar, has converted...
Esperite N.V.: Update to the market on the publication of the Annual Report 2018
June 28, 2019 17:51 ET
|
Esperite N.V.
Esperite N.V. (ESP): Update to the market on the publication of the Annual Report 2018 Amsterdam, The Netherlands – 28 June 2019 Esperite N.V. announced on 30 April 2019 that the publication of the...
ESPERITE (ESP) announces termination of negotiations regarding proposed sale of stem cell banking business to PBKM
June 25, 2019 16:59 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 25 June 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today that the negotiations with Polski Bank Komórek Macierzystych S.A. (WSE: PBKM, “PBKM”)...
ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes
June 14, 2019 02:54 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 14 June 2019 Esperite N.V. (Euronext: ESP, “Esperite”) is pleased to announce that it has agreed an extension of the maturity dates for EUR 4,750,000 in unsecured...
ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM
June 13, 2019 01:17 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 13 June 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today that it has resumed negotiations with Polski Bank Komórek Macierzystych S.A. (WSE: PBKM,...
ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale
May 29, 2019 02:26 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 29 May 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today that the Memorandum of Understanding (MoU) between Esperite and Polski Bank Komórek Macierzystych...
ESPERITE (ESP) announces listing measure by Euronext due to delay in publication of its 2018 annual report (as announced on 30 April 2019)
May 19, 2019 16:54 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 19 May 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today that it has received a notice from Euronext that its ordinary shares will be transferred to...
Esperite N.V. (ESP) : Update to the market on the publica-tion of the Annual Report 2018 and The Cell Factory cur-rent configuration.
May 13, 2019 01:17 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 13 May 2019 Esperite N.V. announced on 30 April 2019 that the publication of the Annual Report 2018 will be delayed. The Company has made significant progress...